Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old.
- You have been diagnosed through a tissue sample (biopsy) with a specific type of high-grade ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (a cancer starting in the lining of the abdomen).
- You are in generally good health and able to carry out daily activities with little or no limitation (confirm with trial site).
- You are able to undergo a keyhole exploratory procedure or surgery to remove as much of the cancer as possible.
- Your cancer has a specific genetic characteristic called homologous recombination deficiency, or HRD (confirm with trial site).
- You have no medical reasons preventing you from receiving chemotherapy or a drug called bevacizumab.
- You are willing and able to sign a consent form to take part in the study.
Who may not be able to join:
- You currently have another active cancer that has spread into surrounding tissues.
- You are pregnant or currently breastfeeding.
- Your cancer has continued to grow or spread while already receiving treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 80291985715
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival; The frequency of adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.